$BBNX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.53 down -35.90% YoY • Reported revenue of $32.01M up 37.76% YoY • Beta Bionics, Inc. maintains its 2026 revenue guidance of $131 million to $136 million and PBP channel reimbursement guidance of 37% to 39%, while raising estimated gross margin to 58.5% to 59.5%.